Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Pharmacologic treatment of spasticity in children.

Tilton A, Vargus-Adams J, Delgado MR.

Semin Pediatr Neurol. 2010 Dec;17(4):261-7. doi: 10.1016/j.spen.2010.10.009. Review.

PMID:
21183133
2.

Pharmacologic interventions for reducing spasticity in cerebral palsy.

Patel DR, Soyode O.

Indian J Pediatr. 2005 Oct;72(10):869-72. Review.

PMID:
16272661
3.

Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Delgado MR, Hirtz D, Aisen M, Ashwal S, Fehlings DL, McLaughlin J, Morrison LA, Shrader MW, Tilton A, Vargus-Adams J.

Neurology. 2010 Jan 26;74(4):336-43. doi: 10.1212/WNL.0b013e3181cbcd2f. Review.

4.

Managing spasticity with drugs.

Simon O, Yelnik AP.

Eur J Phys Rehabil Med. 2010 Sep;46(3):401-10. Review.

5.

[Treatment of spasticity].

Autti-Rämö I.

Duodecim. 1999;115(8):877-85. Review. Finnish. No abstract available.

PMID:
11859520
6.

Pharmacotherapy of spasticity in children with cerebral palsy.

Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P.

Pediatr Neurol. 2006 Jan;34(1):1-6. Review.

PMID:
16376270
7.

[Management of spasticity in children with cerebral palsy].

Matthews DJ, Balaban B.

Acta Orthop Traumatol Turc. 2009 Mar-Apr;43(2):81-6. doi: 10.3944/AOTT.2009.081. Turkish.

8.

Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.

Charles PD, Gill CE, Taylor HM, Putman MS, Blair CR, Roberts AG, Ayers GD, Konrad PE.

Mov Disord. 2010 Mar 15;25(4):466-73. doi: 10.1002/mds.22995.

PMID:
20131401
9.

Spasticity: revisiting the role and the individual value of several pharmacological treatments.

Lapeyre E, Kuks JB, Meijler WJ.

NeuroRehabilitation. 2010;27(2):193-200. doi: 10.3233/NRE-2010-0596. Review.

PMID:
20871149
10.

[Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].

Yelnik AP.

Ann Readapt Med Phys. 2004 Oct;47(8):575-89. Review. French.

PMID:
15465163
11.

[Orally administered drugs in the treatment of spasticity].

Campistol J.

Rev Neurol. 2003 Jul 1-15;37(1):70-4. Review. Spanish.

12.

Drug treatments for spasticity.

Yelnik AP, Simon O, Bensmail D, Chaleat-Valayer E, Decq P, Dehail P, Quentin V, Marque P, Parratte B, Pellas F, Rousseaux M, Trocello JM, Uzzan M, Dumarcet N; Agence française de sécurité sanitaire des produits de santé.

Ann Phys Rehabil Med. 2009 Dec;52(10):746-56. doi: 10.1016/j.rehab.2009.09.005. Epub 2009 Nov 4. No abstract available.

13.

[Pharmacological treatment of spasticity in multiple sclerosis].

Heinzlef O, Monteil-Roch I.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S62-8. doi: 10.1016/S0035-3787(12)70049-8. Review. French.

PMID:
22721367
14.

Pharmacotherapy of spasticity in children with cerebral palsy.

Chung CY, Chen CL, Wong AM.

J Formos Med Assoc. 2011 Apr;110(4):215-22. doi: 10.1016/S0929-6646(11)60033-8. Review.

15.

Botulinum toxin for the management of adult patients with upper motor neuron syndrome.

Esquenazi A, Mayer NH, Elia AE, Albanese A.

Toxicon. 2009 Oct;54(5):634-8. doi: 10.1016/j.toxicon.2009.01.022. Epub 2009 Jan 31.

PMID:
19470335
16.

Pharmacologic management of spasticity in cerebral palsy.

Mooney JF 3rd, Koman LA, Smith BP.

J Pediatr Orthop. 2003 Sep-Oct;23(5):679-86. No abstract available.

PMID:
12960637
17.

Drugs used to treat spasticity.

Kita M, Goodkin DE.

Drugs. 2000 Mar;59(3):487-95. Review.

PMID:
10776831
18.

Principles of pharmaceutical management of spastic hypertonia.

Elovic E.

Phys Med Rehabil Clin N Am. 2001 Nov;12(4):793-816, vii. Review.

PMID:
11727721
19.

Anti-spasticity medications.

Al-Shahrani AM.

Saudi Med J. 2003 Jan;24(1):19-22. Review.

PMID:
12590267
20.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048

Supplemental Content

Support Center